No ban on BPA in food contact materials

There will be no European ban on the endocrine-disrupting chemical Bisphenol A (BPA). The European Parliament has voted that BPA will remain in food contact materials. Wemos regrets that European citizens will therefore remain exposed to this harmful substance.

The European Parliament has accepted the European Commission’s proposal to merely lower the migration limit of BPA in food contact materials. The decision contradicts the Parliament’s own demand for a full ban on BPA in these materials in 2016.

 

‘In 2016, the European Parliament demanded a ban on BPA in food contact materials,’ says Wemos’ global health advocate Renée de Jong. ‘But now it supports a mere reduction of the level of BPA. This is a very disappointing decision – because evidence has shown that BPA can harm our health even in low doses. It is not justifiable that in 2018, chemicals that have been scientifically proven to be endocrine-disruptive are allowed in food contact materials.’

 

BPA leaks from food packaging in our food and drinks

The European Chemicals Agency has registered BPA as a ‘substance of very high concern’ because of its effects on human health. It is an endocrine-disruptor, i.e. it affects our hormone – or endocrine – system and has been linked to fertility problems. Chemicals in food contact materials can leak – or ‘migrate’ – into our food and drinks.

 

The European Parliament’s decision to merely lower the migration limit of BPA in these materials is not radical enough to truly protect the health of all European citizens. Wemos believes that only a full ban will suffice. Moreover, our focus should be broader than just BPA and food contact materials, as there are other known endocrine-disrupting chemicals, such as DEHP in medical devices.

 

Read more about our work on harmful substances

 

Tags: ,

Recent News items

The Foreign Trade and Development Cooperation policy document does not sufficiently address access to healthcare for poorer people

14-07-2022

The new policy paper of Minister Schreinemacher of Foreign Trade and Development Cooperation, “Doen waar Nederland goed in is (“Doing what the Netherlands is good at”), is very much focused on Dutch business interests and seems to have insufficient attention for realising access to health care for poorer population groups. The Minister indicates that she wants to invest more in public-private collaborations in low- and middle-income countries, also in healthcare. As a result, there is a great risk that healthcare will become more commercial and therefore unaffordable for people with fewer financial resources. To provide good healthcare, the Minister should, instead, contribute to strengthening the capacity and financial resources in the public sector. 

Continue reading

What are best practices to address brain drain of health workers?

07-07-2022

What are best (regional) practices when it comes to addressing brain drain – i.e. the emigration of skilled workers, including health workers – and what action is needed on EU level? With this open consultation, the European Commission is interested in feedback on the scale and dynamics of brain drain, and in successful practices and regional strategies and policies to tackle the emigration of qualified workers. Wemos has provided input to the consultation. We recommend, for example, that EU Member States use existing instruments to implement policies and strategies based on evidence, to strengthen their health workforce.

Continue reading